Mycoplasma pneumoniae is an important cause of upper and lower respiratory tract infections, including pharyngitis, tracheobronchitis, and pneumonia, in children and adults of all ages (3, 12). Laboratory diagnosis of M. pneumoniae infection has relied mainly on serologic tests because the organism is hard to isolate (5,6,9,11,18). A reliable and sensitive serologic test for use in the early phase of infection by M. pneumoniae is needed to confirm the infection and to ensure that the appropriate antibiotic is used for treatment. The detection of specific immunoglobulin M (IgM) antibody, which appears 7 to 10 days after infection and approximately 2 weeks before IgG antibody, has been shown to indicate a recent or current infection with M. pneumoniae (10,(14)(15)(16). However, the presence of IgM in adult serum does not always indicate a current infection, because in some cases IgM has been shown to persist for up to a year after infection. In addition, the IgM response is either minimal or undetectable in some cases of adult reinfection with M. pneumoniae (5,10,16,19). Therefore, reliance on the detection of specific IgM alone, especially in an adult population, could allow some infections to be missed. In a previous study (19), approximately 20% of adults did not mount an IgM response after infection with M. pneumoniae.We tested paired serum specimens, obtained from 64 adult patients with probable M. pneumoniae respiratory infections, with three commercial enzyme immunoassays (EIAs): the ImmunoCard (IC) mycoplasma EIA (Meridian Diagnostics, Cincinnati, Ohio), the Remel EIA M. pneumoniae IgG-IgM antibody test system (Remel, Lenexa, Kans.), and the ImmunoWELL-IgM EIA (GenBio, San Diego, Calif.), now marketed through Alexon-Trend, Ramsey, Minn. The paired samples were also tested with a complement fixation (CF) assay, considered to be the serologic "gold standard," to determine if a more timely diagnosis of M. pneumoniae could be obtained in the early phase of infection.
MATERIALS AND METHODSSera. Acute-and convalescent-phase sera were obtained from 64 patients during suspected outbreaks of respiratory infections caused by M. pneumoniae (4, 13). Most of the patients had chest X rays with infiltrates compatible with atypical pneumonia. Other features of the infections included cough, fever, and myalgias. Sera were held at Ϫ20°C before being tested by the Meridian IC, ImmunoWELL-IgM, Remel EIA, and CF tests. Twenty-one paired serum samples from an outbreak of respiratory illness due to parainfluenza virus were also tested with each of the assays. None of the serum samples were linked to individual patient identifiers.Meridian IC. The Meridian IC mycoplasma EIA is a qualitative procedure for the detection of IgM antibodies to M. pneumoniae in human serum. The test was performed according to the manufacturer's instructions. Briefly, the test system consists of a plastic card with four openings that provide access to absorbent filter paper. The filter paper is impregnated with an M. pneumoniae antigen extract in the to...